FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
VANTA BIOSCIENCE LIMITED Corporate Identification Number: U74999TG2016PLC109280 Our Company was originally incorporated as a private limited company under the Companies Act 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name 'Vanta Biosciencs Private Limited'. Our Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on february 13, 2017 and consequently, the name of our Company was changed to 'Vanta Bioscience Limited' and a fresh certificate of incorporation consequent upon conversion in public Smiled company was issued by the Registrar of Companies, Hyderabad on March) 17,2017.for further details of our Company, see 'General Information' and 'History and Certain Other Corporate Matters' on pages 41 and 86. respectively. Registered Office: No 02/G/308/G, NO.3/FF/SF/1-20-248
Umajay Complex, Rasoolpura, Secunderabad, Hyderabad - 500 003, Telangana, India. PROMOTERS OF THE COMPANY: MOHAN KRISHNA MULAKALA. DOPESH RAJA
MULAKALA, BASIS OF ALLOTMENT PUBLIC ISSUE OF 15.12.000 EQUITY SHARES OF FACE VALUE OF RS 10.00 EACH OF VANTA
BIOSCIENCE LIMITED ('OUR COMPANY' OR 'THE ISSUER') FOR CASH AT A PRICE
OF RS 50.00 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OF RS 40.00 PEP EQUITY SHARE)
('ISSUE PRICE') AGGREGATING TO RS 756.00 LAKHS ('THE ISSUE'). OF THE
ISSUE, 78.000 EQUITY SHARES AGGREGATING TO RS 39.00 LAKHS WILL BE RESERVED FOR
SUBSCRIPTION BY MARKET MAKER ('MARKET MAKER RESERVATION PORTION') THE ISSUE LESS
THE MARKET MAKER RESERVATION PORTION I. E. ISSUE OF 14,34,000 EQUITY SHARES OF FACE VALUE
OF RS 10.00 EACH AT AN ISSUE PRICE OF RS 50.00 PER EQUITY SHARE AGGREGATING TO RS 717.00
LAKHS IS HEREINAFTER REFERRED TO AS THE 'NET ISSUE'. THE ISSUE AND THE NET ISSUE
WILL CONSTITUTE 26.40% AND 25.03%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE
CAPITAL OF OUR COMPANY. THE FACE VALUE OF THE EQUITY SHARES IS RS 10 EACH AND The Equity Shares offered through this Prospectus are proposed to be listed on the
BSE SME Platform. In terms of the Chapter XB of the SEBI (ICDR) Regulations. 2009. as
amended from time to time, we are not required to obtain an in-principal listing approval
for the shares being Offered in this Issue. However, our Company has received an approval
letter dated August 24, 2017 from BSE for using its name in this Prospectus for listing of
our Equity Shares on the SME Patform of BSE For the purpose of this Issue, BSE Limited
shall be the Designated Stock Exchange. The trading is proposed to be commenced with
effect from FRIDAY, OCTOBER 6.2017*. SUBSCRIPTION DETAILS The Issue has received 345 applications for 16386000 Equity Shares resulting in 1.12
times subscription (including reserved portion of Markal Maker). Due to technical
rejections the issue was undersubscribed Since this Issue was fully underwritten, and
requisite notice was sent to Underwriter i.e. Inventure Growth & Securities Limited
hence Underwriter has arranged for subscription for the shortfall of Equity Shares and
accordingly Issue was fully subscribed. The details of the applications received in the
Issue (before technical rejections and after returns due to unblocked amount) are as
follows:
The details of applications rejected by the Registrar on technical grounds / withdrawal are detailed below: Technical rejection,/ Withdrawal
After eliminating Technically Rejected applications, the following table gives the details of Category wise net valid applications; Alter technical rejections
Since the issue is fully underwritten the shortfall of 453000 equity shares aggregating
to Rs 22650000.00 was arranged by the Underwriter in terms of the Underwriting agreement
dated August 24.2017.
D. Allocation to Underwriters (After Technical Rejections): The
subscription for the shortfall of 453000 Equity Shares has been arranged by Underwriter at
the issue price of Rs 50 per Equity Shares. The under subscribed 90000 & 363000 shares
respectively from both Retail category & Non Retail category have been allotted to
Underwriter category. The Basis of Allotment for Underwriter Category at the issue price
of Rs 50 per Equity Share, was finalized in consultation with BSE. The total number of
shares allotted in this category is 4,53,000 Equity Shares to one Applicant. INVESTORS PLEASE NOTE The details of the allotment mads would also be hosted on the website of the Registrar to the issue, BIGSHARE SERVICES PRIVATE LIMITED at www.bigshareonline.com. All future correspondence In this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Rank Branch where the application had been lodged and payment details at the address of the Registrar given below: BIGSHARE SERVICES PRIVATE LIMITED
|
The IPO allocation is based on the subscription level and the investor category.
Refer to IPO allotment rules and methods for more details.
See the basis of allotment document above to know how the shares are allocated in Vanta Bioscience IPO .
The Vanta Bioscience IPO basis of allotment (published above) tells you how shares are allocated to you in Vanta Bioscience IPO and category wise demand of IPO share.
Visit the Vanta Bioscience IPO allotment status page to check the number of shares allocated to your application.
In Vanta Bioscience IPO allotment process, the registrar separates valid and invalid applications. The invalid applications with technical errors are rejected and only valid applications at or above the cut-off price are considered for allotment.
For more information, please refer to IPO Allotment Process and Basis of Allotment.
Check the Vanta Bioscience IPO basis of allotment document to know how the shares are allocated in Vanta Bioscience IPO.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|